This study investigates the effects of 6 months of intensive Galileo Therapy (18-22 Hz, pos. 4, 3/week, 4 exercises: tip-toe, half squat, one legged half squat) in patients with chronic fatigue syndrome (CFS). Galileo Therapy showed significant improvements of the muscle functions of the legs (+84%) but also the upper body (+15-33%) and in subjective parameters (VAS-score) like mood, pain, endurance and quality of life (55-68%).
These typical effects of Galileo Therapy can also be observed e.g. in COPD #GRFS41 #GRFS33 #GRFS32 or in aging in general #GRFS42. The relevant effect of Galileo Therapy is the essential improvement of muscle power, because the muscle power is compromised by the simple fact of disease related disuse. Even more effective would have been to use smaller amplitudes (Pos.2) but higher frequencies (26-30Hz) because frequency is more efficient in muscle activation #GRFS3.
#GRFS71 #GalileoTherapy #CFS #ChronicFatigueSyndrome #MusclelFunction #Endurance #Pain #MechanoStimulation
The verdict of our customers: Excellent
4.7 out of 5 stars based on 868 reviews
Since 1996 we support our Galileo® customers worldwide.
Development and production exclusively in Germany.
10-year service guarantee &
5 year warranty for private customers in Germany
Unlimited user support for all Galileo customers.
Efficacy proven by over 500 scientific publications.
Winter vacation
Dear customers,
Our colleagues have been working for you and your wishes all year – now we’re giving them a well-deserved break. From 24.12.2025 to 6.1.2026, we’re swapping phones for Christmas movies and to-do lists for plates of cookies.
However, our contact form remains as vigilant as a Christmas angel – feel free to write to us and we will get back to you on January 7, 2026, when we are back, refreshed and full of energy!
Merry Christmas and a magical new year
Your Galileo Team
You are currently viewing a placeholder content from Vimeo. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from YouTube. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou need to load content from reCAPTCHA to submit the form. Please note that doing so will share data with third-party providers.
More Information